Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered answering member label attachment file name file name title title
tabling member	label

Search

577010

	registered interest
	date	06/09/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Zika Virus: USA
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what warnings they are giving to prospective UK visitors to the USA about the dangers of contracting Zika virus, and whether they will highlight the most dangerous areas in the USA.
	tabling member printed	Lord Blencathra
	uin	HL1607
	answer	answer is ministerial correction date of answer 16/09/2016 answer text <p>Public Health England (PHE) and the National Travel Health Network and Centre (NaTHNaC) introduced a risk-based approach for countries reporting Zika infection ahead of cases reported from Florida in the United States of America. PHE and NaTHNaC issued travel guidance about Florida as soon as cases were announced. A copy of this guidance is attached. The first locally acquired cases of Zika were reported from Florida on 29 July 2016. The guidance advised pregnant women to consider postponing non-essential travel to Florida. Links to NaTHNaC’s detailed, site-specific advice allowed clinicians to have in-depth discussions of the transmission risks in Florida with potential travellers.</p><p>A high risk alert was issued as more information became available stating: “The risk in Miami-Dade county is considered high and pregnant women are advised to postpone non-essential travel to Miami-Dade county until after their pregnancy.” Advice on reducing the risk of sexual transmission of Zika infection was also issued, which is included within the attached guidance.</p><p>The situation is constantly under review and assessment, and travel and sexual transmission guidance is updated regularly as new information emerges from Florida.</p> answering member printed Lord Prior of Brampton question first answered 16/09/2016 11:05:48 answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name PQ Zika Virus advice on NaTHNaC website HL1607.pdf title Zika advice
	tabling member	497 label Biography information for Lord Blencathra

449684

	registered interest
	date	02/02/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Zika Virus: Pregnancy
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government whether the Department of Health has begun to carry out a survey of pregnant women where either partner has been to Brazil or other neighbouring countries where there has been a significant outbreak of the Zika virus.
	tabling member printed	Lord Maginnis of Drumglass
	uin	HL5766
	answer	answer is ministerial correction date of answer 12/02/2016 answer text <p>Public Health England (PHE) is actively exploring the feasibility of working with other parts of the United Kingdom to undertake the systematic collection of data on pregnant women presenting to National Health Service maternity services where they have travelled to a country with active Zika virus transmission during pregnancy or within four weeks of conception. The aim of such work would be to measure the impact of Zika virus on obstetric services and on pregnancy and pregnancy outcomes for women.</p><p> </p><p>PHE has been working with appropriate Royal Colleges to provide updated guidance for healthcare professionals, including midwives, on the management of any symptomatic patients (particularly pregnant women) returning from affected countries. A copy of this guidance is attached.</p> answering member printed Lord Prior of Brampton question first answered 12/02/2016 08:29:51 answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name Guidance for healthcare professionals HL5766.pdf title Guidance for healthcare professionals Zika
	tabling member	648 label Biography information for Lord Maginnis of Drumglass

449682

	registered interest
	date	02/02/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Zika Virus
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government how and when they intend to introduce and implement a comprehensive plan in relation to the Zika virus to (1) inform fully the British public about that virus, (2) advise on travel to Central and South America in the light of that virus' prevalence in that region, and (3) clarify all known means of transmission of that virus.
	tabling member printed	Lord Maginnis of Drumglass
	uin	HL5764
	answer	answer is ministerial correction date of answer 11/02/2016 answer text <p>Public Health England (PHE) and the National Travel Health Network and Centre have issued travel advice to people who may be travelling to the affected countries, particularly pregnant women and provided information for the general public through the NHS Choices website.</p><p> </p><p>PHE has been working with appropriate professional groups to develop information and guidance on Zika for clinicians. They have worked in partnership with the Royal College of General Practitioners (RCGP) to develop specifically targeted at primary care which is available on the PHE website and has been cascaded by the RCGP. A copy of this guidance is attached.</p><p> </p><p>PHE have also issued a Central Alerting System update alert letter to clinicians, which includes specific information and guidance about Zika virus and pregnancy and general guidance on Zika virus and travel. A copy of this is attached.</p><p> </p><p>Although some evidence of sexual transmission exists and there is the possibility that blood transfusions may be able to transmit the virus this will be very rare. Transmission from mother to fetus via the placenta is also possible. If a person acquires Zika abroad and becomes ill on their return to the United Kingdom, mosquito-borne transmission will not occur as the mosquito is not present in the UK.</p><p> </p><p>Information on these issues is available on the PHE website. The Government continues to monitor this situation very closely and will continue to take action as appropriate.</p><p><strong> </strong></p><p><strong> </strong></p> answering member printed Lord Prior of Brampton attachment 1 file name Zika_virus_guidance_for_primary_care_February_2016_FINAL.pdf title Guidance for clinicians 2 file name Final CAS alert letter Zika with updated annex (1).pdf title Central Alert System letter to clinicians question first answered 11/02/2016 17:45:04 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	648 label Biography information for Lord Maginnis of Drumglass

525084

	registered interest
	date	14/06/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Zero Hours Contracts
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what assessment they have made of how England compares with other European countries in (1) one, (2) five, and (3) 10-year survival rates for patients diagnosed with metastatic kidney cancer.
	tabling member printed	Baroness Cumberlege
	uin	HL671
	answer	answer is ministerial correction date of answer 28/06/2016 answer text <p>No formal assessment has been made.</p><p> </p><p>Although cancer survival rates are at a record high and continue to improve, we know that we have to strive to be better. The independent Cancer Taskforce report, <em>Achieving World-Class Cancer Outcomes: A strategy for England 2015-2020</em>, published in July last year, recommends improvements across the cancer patient pathway. A copy of the report is attached.</p><p> </p><p>NHS England is currently working with partners across the health system to deliver the Cancer Taskforce’s recommendations. An implementation plan, <em>Achieving World-Class Cancer Outcomes: Taking the strategy forward</em>, was published on 12 May 2016 and we hope to see great progress as it is delivered. A copy of the implementation plan is attached.</p> answering member printed Lord Prior of Brampton attachment 1 file name Achieving World-Class Cancer Outcomes - A strategy for England 2015-2020.pdf title A strategy for England 2 file name Achieving world-class cancer outcomes -Taking the strategy forward.pdf title Taking the strategy forward question first answered 28/06/2016 13:31:37 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2729 label Biography information for Baroness Cumberlege

456355

	registered interest
	date	01/03/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Wound Dressings:: Supply Chains
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what action they will take to ensure that the NHS Supply Chain wound dressing generics project takes account of evidence comparing the cost of managing unhealed and healed wounds, and of the total cost of wound care in the NHS currently as compared with previous estimates.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL6589
	answer	answer is ministerial correction date of answer 10/03/2016 answer text <p>The review of wound dressings by a dedicated working group resulted in the development of a number of clinical specifications for wound care products.</p><p> </p><p>In order to progress this work, from April 2016 a new NHS Clinical Evaluation Team will be put in place. The Clinical Evaluation Team will assess wound care products through a comprehensive evaluation process, which will have extensive engagement with NHS clinical staff. Included in the process will be tissue viability and infection control nurses, clinical procurement specialists, doctors, nurses and midwives along with medicine management practitioners from community trusts.</p><p> </p><p>The project’s remit is to review clinical products to identify those that enable high quality patient care whilst delivering the best outcomes for the NHS. The secondary consideration will be to identify products that could be procured more effectively through combined NHS buying power, to deliver greater overall value for money.</p><p> </p><p>The Clinical Evaluation Team is made up of practising clinicians.</p><p>The project will therefore undertake assessments of the total costs and benefits of any recommendations to the overall NHS.</p><p> </p><p> </p><p> </p> answering member printed Lord Prior of Brampton question first answered 10/03/2016 15:05:00 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

456354

	registered interest
	date	01/03/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Wound Dressings: Procurement
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government whether, in the light of their review of the cost of wound dressings to the NHS, they will ensure that clinical expertise is a full component part of the process in order to ensure that the outcome is clinically effective as well as cost-effective.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL6588
	answer	answer is ministerial correction date of answer 10/03/2016 answer text <p>The review of wound dressings by a dedicated working group resulted in the development of a number of clinical specifications for wound care products.</p><p> </p><p>In order to progress this work, from April 2016 a new NHS Clinical Evaluation Team will be put in place. The Clinical Evaluation Team will assess wound care products through a comprehensive evaluation process, which will have extensive engagement with NHS clinical staff. Included in the process will be tissue viability and infection control nurses, clinical procurement specialists, doctors, nurses and midwives along with medicine management practitioners from community trusts.</p><p> </p><p>The project’s remit is to review clinical products to identify those that enable high quality patient care whilst delivering the best outcomes for the NHS. The secondary consideration will be to identify products that could be procured more effectively through combined NHS buying power, to deliver greater overall value for money.</p><p> </p><p>The Clinical Evaluation Team is made up of practising clinicians.</p><p>The project will therefore undertake assessments of the total costs and benefits of any recommendations to the overall NHS.</p><p> </p><p> </p><p> </p> answering member printed Lord Prior of Brampton question first answered 10/03/2016 15:04:20 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

456356

	registered interest
	date	01/03/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Wound Dressings: Procurement
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 4 January (HL4800), whether they are aware of any limitations regarding the data contained in the Nursing Times report in December 2014, in particular its accuracy and relevance to the UK.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL6590
	answer	answer is ministerial correction date of answer 10/03/2016 answer text <p>There were 856 responses to the Royal College of Nursing survey run by Nursing Times in December 2014. The respondents were keen to get involved in the procurement process and recognised opportunities to save money.</p><p> </p><p>The respondents to the survey included a broad spectrum of nursing staff, the breakdown of which was as follows: 35% Staff nurses, 31% Clinical nurse specialists; 16% ward sisters; 10% Senior nurse managers; 4% Healthcare Assistants; 1% Directors of Nursing; and 1% Student nurses. 74% of respondents to the survey saw opportunities to reduce duplication on wound care products.</p> answering member printed Lord Prior of Brampton question first answered 10/03/2016 15:05:56 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

456357

	registered interest
	date	01/03/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Wound Dressings: Prices
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government whether they plan to consider restructuring the NHS Drug Tariff Part IX on wound dressings based on their clinical performance and intended use.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL6591
	answer	answer is ministerial correction date of answer 10/03/2016 answer text <p>The scope of the Department’s clinical specifications project is to assess wound care products available via the NHS Supply Chain to secondary care organisations. There are no plans at this time to extend this scope to include wound care products listed in Part IX of the Drug Tariff, which can be prescribed in primary care at National Health Service expense.</p><p> </p><p> </p> answering member printed Lord Prior of Brampton question first answered 10/03/2016 14:03:46 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

456358

	registered interest
	date	01/03/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Wound Dressings
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 4 January (HL4800), what evidence they have that suggests that the complexity of choice in wound dressings for nurses and clinicians makes their clinical decisions more difficult and can lead to over-specification and variation in standards of care.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL6592
	answer	answer is ministerial correction date of answer 10/03/2016 answer text <p>The NHS Catalogue contained over 600,000 products, many of which had been not used in excess of the last 12 months or were seemingly duplicate items. Given the sheer volume of products, this creates the complexity faced by clinicians and nurses when determining the appropriate products to use, which directly makes their decisions more difficult.</p><p>By undertaking the planned clinical rationalisation of the products available via NHS Supply Chain, the Department aims to reduce this complexity, removing unnecessary products, ensuring that those available to the National Health Service are of an appropriate specification in order to maintain high standards of patient care.</p><p>The clinical rationalisation work is being undertaken by practising clinicians taking into account feedback from the National Institute for Health and Care Excellence and other relevant programmes, such as ‘ Getting it Right First Time’.</p> answering member printed Lord Prior of Brampton question first answered 10/03/2016 15:21:28 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

521039

	registered interest
	date	24/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	World Heritage Sites
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what is their estimate of the shortfall in resources available to enable elderly and disabled patients to be discharged from hospitals with adequate provision in place for their appropriate care at home or elsewhere.
	tabling member printed	Lord Ouseley
	uin	HL288
	answer	answer is ministerial correction date of answer 07/06/2016 answer text <p>No-one should stay in hospital any longer than they need to and this Government is determined to ensure that health and social care are properly funded. As well as funding the National Health Service’s own plan for the future with £10 billion, we are giving local authorities access to up to £3.5 billion extra for adult social care by 2019/2020 through the new Social Care Precept and additional social care funding in the Better Care Fund.</p> answering member printed Lord Prior of Brampton question first answered 07/06/2016 11:27:00 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2170 label Biography information for Lord Ouseley